RAK MOLOChNOY ZhELEZY U MUZhChIN


Cite item

Full Text

Abstract

Рак молочной железы (РМЖ) у мужчин - редко встречающееся заболевание, изучение которого в рамках рандомизированных клинических испытаний затруднено из-за его редкости. В основном, данные о РМЖ у мужчин были собраны, благодаря ретроспективным исследованиям за последние несколько десятилетий. Интерес к РМЖ у мужчин возрастает из-за увеличения распространения этого заболевания. Представлены сведения о патогенезе, принципах диагностики и лечения РМЖ у мужчин.

References

  1. Семиглазов В.Ф., Семиглазов В.В., Клецель А.Е. Рак молочной железы у мужчин // Неинвазивные и инвазивные опухоли молочной железы. Спб., 2006. С. 288-299.
  2. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
  3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
  4. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
  5. Crichlow K, Kaplan E, Kearny W. Male mammary cancer An analysis 32 cases. Ann Surg 1972;175:489.
  6. Fodor P. Breast cancer in patient with gynecomastia. Plast Reconstr Surg 1989;84:976-79.
  7. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
  8. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
  9. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-90.
  10. Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002;4:R2.
  11. Ottini L, Masala G, D'Amico C, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003;63:342-7.
  12. Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.
  13. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-9.
  14. Kwiatkowska E, Teresiak M, Filas V, et al. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 2003;9:4452-9.
  15. Singletary E. Breast cancer. Houston. 2008:591.
  16. Холдин С.А.. Дымарский Л.Ю. Расширенные радикальные операции при раке молочной железы. Л., 1975. 232 с.
  17. Баженова А.П., Островцев Л.Д., Хахацишвили Г.Н. Рак молочной железы. Л., 1985. 272 с.
  18. Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55-60.
  19. Семиглазов В.Ф., Семиглазов В.В., Дашян Г.А. Обоснование показаний к различным видам терапии ранних стадий рака молочной железы (по материалам Сан-Галлена, 2009). М., 2009. 62 с.
  20. Giordano SH, Perkins G, Garcia SM, et al. Male breast cancer: the M. D. Anderson experience with adjuvant therapy. Breast Cancer Res Treat 2003;82:S42.
  21. Giordano SH, Valero V, Buzdar AU, et al. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 2002;25:235-7.
  22. Zabolotny BP, Zalai CV, Meterissian SH. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol 2005;90:26-30.
  23. Italiano A, Largillier R, Marcy PY, et al. Complete remission obtained with letrozole in a man with metastatic breast cancer. Rev Med Interne 2004;25:323-4.
  24. Vorobiof D, Falkson C. Nasally administered buserelin including complete remission of lung metastases in male breast cancer. Cancer 1987;59:688-9.
  25. Labrie F, Dupont A, Belanger A, et al. Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report. Clin Invest Med 1990;13:275-8.
  26. Lopez M, Natali M, Di Lauro L, et al. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer 1993;72:502-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies